Board of Directors
Pursuant to the Articles of Association of Bioretec, the company's Annual General Meeting elects a minimum of three (3) and a maximum of seven (7) board members. The term of office of members of the Board of Directors begins from the Annual General Meeting at which they are elected and expires at the end of the Annual General Meeting following the election.
In addition to the duties defined in laws and regulations and Bioretec's Articles of Association, the duties of Bioretec's Board of Directors include the following:
- to guide and supervise Bioretec's management and operations;
- to decide on significant matters pertaining to Bioretec's operations;
- to review and approve Bioretec's half-year reports, reports by the Board of Directors and financial statements;
- to approve Bioretec' strategy, business plans and certain Bioretec's policies and practices, as well as to supervise their application;
- to decide on significant business acquisitions, investments and divestments; and
- to define Bioretec's dividend policy.
Board committees add
Bioretec's Board of Directors has two permanent committees: the Audit Committee and the Nomination/Remuneration Committee, which assist the Board in the preparation of matters falling within its competence. The Board of Directors elects the members of these committees from among its members in connection with its annual constitutive meeting and supervises their work during the term of office.
- Audit Committee: Päivi Malinen (Chairperson), Michael Piccirillo and Sarah van Hellenberg Hubar-Fisher
- Remuneration Committee: Sarah van Hellenberg Hubar-Fish (Chairperson), Antti Vasara and Justin Barad.
Board of Directors
Kustaa Poutiainen
Chairman of the Board of Directors
Member of the Board since 2023
Born 1956
Finnish citizen
MSc in Economics from Helsinki School of Economics
Background add
Main work experience:
- Stephen Industries Inc Oy, president and chairman of the board 1992
Positions of trust:
- KP-Tekno Oy, chairman of the board
- IF Gnistan Oy, vice-chairman of the board
Holdings in the company:
- 2,556,370 shares indirectly through Stephen Industries Inc Oy, 25,000 option rights entitling the subscription of 25,000 shares.
Independent from the company, but not independent from major shareholders
Sarah van Hellenberg Hubar-Fisher
Board member
Member of the Board since 2021
Vice chair of the Board of Directors
Member of the Audit Committee
Member of the Remuneration Committee
Born 1978
Citizen of the United States and the Netherlands
Education: MBA, M.Sc Nutritional Epidemiology and Public Health
Background add
Main work experience:
- Global Public Health Financing Lead & MedTech External Innovation at Johnson & Johnson.
- Supervisory Board roles: Global Surgical Initiatives (active), WillemPie (active), UVA Ventures (2020-2023).
- Advisory Board roles: Nen.health Castor EDC, RespiQ.
- Venture Partner: Growth Science Ventures (2017-2023) and Nina Capital (2019-2023)
Holdings in the company:
- 0 shares, 1,025,000 option rights entitling the subscription of 91,666 shares.
Independent from the company and major shareholders
Justin Barad
Board member
Member of the Board since 2025
Member of the Remuneration Committee
Born 1982
United States citizen
MD: Bioengineering degree from UC Berkeley and an MD from UCLA
Background add
Main work experience:
- Co-founder and Chief Strategy Officer of Osso VR
- Continues practicing pediatric orthopedic trauma at UCLA Health and the Luskin Orthopedic Institute for Children.
Positions of trust:
- Member of the UCLA Biodesign Innovation Board
Holdings in the company:
- 0 shares, 25,000 option rights entitling the subscription of 25,000 shares.
Independent from the company and major shareholders
Michael Piccirillo
Board member
Member of the Board since 2018
Member of the Audit Committee
Born 1959
Citizen of Switzerland and the United Kingdom
Education: B.Sc. Microbiology, BBA
Background add
Main work experience:
- Managing Director, VALUGEN GmbH.
- Executive Director, AO Spine and AO Trauma
- VP of surgeon education, NuVasive
- CEO of VR simulation, Symgery
Position of Trust:
- Chief Customer Engagement Officer SEeCURE,
- Member Board of Directors GSCOne
Holdings in the company:
- 10 000 shares, 1,025,000 option rights entitling the subscription of 91,666 shares.
Not independent from the company, but independent from major shareholders
Päivi Malinen
Board member
Member of the Board since 2022
Chairman of the Audit Committee
Born 1972
Finnish citizen
Education: Master of Laws LL.M., Law
Background add
Main work experience:
- Laissa Oy, partner
- CEO of IR Partners Oy and Springvest Oyj
Positions of trust:
- Wapaaluoto Oy, board member
Holdings in the company:
- 5,390 shares, 625,000 option rights entitling the subscription of 65,000 shares. Additionally 1,300 shares held through Wapaaluoto Oy.
Independent from the company and major shareholders
Antti Vasara
Board member
Member of the Board since 2025
Member of the Remuneration Committee
Born 1965
Finnish citizen
Doctor of Science (Technology)
Background add
Positions of trust:
- Elisa Corporation Ltd, member of the board
- Jane and Aatos Erkko Foundation, member of the board
- Ilmarinen Mutual Pension Insurance Company, member of the board
Holdings in the company:
- 0 shares, 25,000 option rights entitling the subscription of 25,000 shares.
Independent from the company and major shareholders
Connect
Contact us© 2025 Bioretec Ltd. All rights reserved. Specifications are subject to change without notice.
Privacy Policy